Our panel of experts explore the pathophysiology of vasomotor symptoms in menopause and their impact on quality of life, assess the role of neurokinin receptor antagonists, and discuss strategies for incorporating these novel options into practice to optimize patient care.
EP. 1: Impact of Vasomotor Symptoms on Patient Quality of Life
Panelists discuss how vasomotor symptoms undermine physical comfort, sleep, and long-term health, emphasizing integrative management to restore overall quality of life.
EP. 2: Pathophysiology of Vasomotor Symptoms in Menopause
Panelists discuss how hormonal decline and KNDy neuron overactivation drive vasomotor symptoms and inform the development of targeted neurokinin receptor therapies.
EP. 3: Unmet Needs in Managing Vasomotor Symptoms in Menopause
Panelists discuss how limited treatment options and systemic barriers underscore the urgent need for accessible, targeted therapies for vasomotor symptoms.
EP. 4: NK Receptor Antagonism as Therapeutic Strategy for Vasomotor Symptoms
Panelists discuss how NK receptor antagonism provides a targeted, nonhormonal strategy that addresses the physiological root of vasomotor symptoms.